Literature DB >> 59171

Letter: Prostaglandin E1 for interrupted aortic arch in the neonate.

D J Radford, K R Bloom, F Coceani, R Fariello, P M Olley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59171     DOI: 10.1016/s0140-6736(76)92309-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.

Authors:  S C Reddy; A Saxena
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

2.  Administration of E-type prostaglandins in ductus-dependent congenital heart disease.

Authors:  E D Silove
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

3.  Interrupted aortic arch: natural history and operative results.

Authors:  G Schumacher; R Schreiber; H Meisner; H P Lorenz; F Sebening; K Bühlmeyer
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

4.  Effect of prostaglandin on early surgical mortality in obstructive lesions of the systemic circulation.

Authors:  F Leoni; J C Huhta; J Douglas; R MacKay; M R de Leval; F J Macartney; J Stark
Journal:  Br Heart J       Date:  1984-12

5.  Prostaglandin E1 infusion in newborns with hypoplastic left ventricle and aortic atresia.

Authors:  A R Hastreiter; R L van der Horst; B Sepehri; I W DuBrow; E A Fisher; S Levitsky
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

6.  Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.

Authors:  F Coceani; P M Olley; J E Lock
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

7.  Constriction of juxta-ductal aorta and rapid progression of obstruction in a newborn.

Authors:  Neeraj Awasthy; Munesh Tomar; Sitaraman Radhakrishnan; Krishna Subramoney Iyer
Journal:  Ann Pediatr Cardiol       Date:  2010-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.